Skip to content

Camba-Pharma

Active Risk: not assessed
Private limited companyfounded 2019active for 7 yearsDroogveldeweg 7, 9031 Gent, BelgiumKBO/BCE: BE 0717.740.414
Summary

Camba-Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €137,100 and a net result of €47,651. Equity is growing by about 40% per year across the filed financial years. Its solvency ranks better than 48% of 22,576 sector peers (NACE 47, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.

Financials · financial year 2025, micro format

Equity
€137,100▲ 31.3%
2024 · €104,449
Total assets
€437,825▼ 4.1%
2024 · €456,352
Net result
€47,651▲ 28.9%
2024 · €36,955
Working capital
-€80,554▼ 17.7%
2024 · -€68,461
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

After the dip in 2023 the operating result has climbed two years in a row; 2025 is 22% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€68,885 2025 Net result€47,651 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€5,320-€31,266▲ 488%€32,745▲ 4.7%€49,945▲ 52.5%€48,873▼ 2.1%€56,550▲ 15.7%€68,885▲ 21.8%
Net result€2,720-€19,885within the sector's middle half▲ 631%€20,240within the sector's middle half▲ 1.8%€31,841above the sector's middle half▲ 57.3%€32,054above the sector's middle half▲ 0.7%€36,955above the sector's middle half▲ 15.3%€47,651above the sector's middle half▲ 28.9%
Equity€8,108-€27,193within the sector's middle half▲ 235%€59,833within the sector's middle half▲ 120%€50,441within the sector's middle half▼ 15.7%€67,494within the sector's middle half▲ 33.8%€104,449within the sector's middle half▲ 54.8%€137,100above the sector's middle half▲ 31.3%
Total assets€15,493-€244,805within the sector's middle half▲ 16×€265,702within the sector's middle half▲ 8.5%€458,890above the sector's middle half▲ 72.7%€457,640above the sector's middle half▼ 0.3%€456,352above the sector's middle half▼ 0.3%€437,825above the sector's middle half▼ 4.1%
Debt€7,385-€217,611▲ 29×€205,869▼ 5.4%€408,449▲ 98.4%€390,145▼ 4.5%€351,903▼ 9.8%€300,724▼ 14.5%
Working capital€5,270--€10,373below the sector's middle half€5,962within the sector's middle half-€53,579below the sector's middle half-€74,019below the sector's middle half▼ 38.2%-€68,461below the sector's middle half▲ 7.5%-€80,554below the sector's middle half▼ 17.7%
Solvency52.3%-11.1%within the sector's middle half▼ 41.2pp22.5%within the sector's middle half▲ 11.4pp11.0%within the sector's middle half▼ 11.5pp14.7%within the sector's middle half▲ 3.8pp22.9%within the sector's middle half▲ 8.1pp31.3%within the sector's middle half▲ 8.4pp
Current ratio1.76-0.72below the sector's middle half▼ 1.041.14within the sector's middle half▲ 0.420.33below the sector's middle half▼ 0.810.26below the sector's middle half▼ 0.070.27below the sector's middle half▲ 0.010.08below the sector's middle half▼ 0.19
Return on assets (ROA)17.6%-8.1%within the sector's middle half▼ 9.4pp7.6%within the sector's middle half▼ 0.5pp6.9%within the sector's middle half▼ 0.7pp7.0%within the sector's middle half▲ 0.1pp8.1%within the sector's middle half▲ 1.1pp10.9%within the sector's middle half▲ 2.8pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €437,825
Fixed assets €431,108 ▼ 0.1%
Current assets €6,717 ▼ 73.0%
Equity and liabilities €437,825
Equity €137,100 ▲ 31.3%
Debt €300,724 ▼ 14.5%
Debt's share of the balance-sheet total falls from 77.1% to 68.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
ROE
34.8%▼
2024 · 35.4%
Debt ≤ 1 year
€87,271▼
2024 · €93,336
Debt > 1 year
€212,664▼
2024 · €251,488
Income taxes
€16,590▲
2024 · €13,922
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€456,352€437,825▼
Fixed assets21/28€431,477€431,108▼
Tangible fixed assets22/27€1,477€1,108▼
Furniture and vehicles24€1,477€1,108▼
Financial fixed assets28€430,000€430,000=
Current assets29/58€24,875€6,717▼
Amounts receivable within one year40/41€19,264-
Trade receivables40€19,264-
Cash at bank and in hand54/58€5,527€6,440▲
Deferred charges and accrued income490/1€85€277▲
Equity and liabilities
Total equity and liabilities10/49€456,352€437,825▼
Equity10/15€104,449€137,100▲
Contributions10/11€18,600€18,600=
Reserves13€85,849€118,500▲
Distributable reserves133€85,849€118,500▲
Amounts payable17/49€351,903€300,724▼
Amounts payable after more than one year17€251,488€212,664▼
Financial debts170/4€251,488€212,664▼
Amounts payable within one year42/48€93,336€87,271▼
Current portion of amounts payable after more than one year42€41,492€42,037▲
Financial debts43€3,884€4,890▲
Other loans439€3,884€4,890▲
Trade debts44€321€8,850▲
Suppliers440/4€321€8,850▲
Advances received on contracts in progress46€22,385-
Taxes, remuneration and social security45€7,686€11,626▲
Taxes450/3€7,686€11,626▲
Other amounts payable47/48€17,568€19,868▲
Accrued charges and deferred income492/3€7,078€790▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€369€369=
Other operating charges640/8€141€144▲
Gross operating margin9900€57,060€69,398▲
Operating profit (loss)9901€56,550€68,885▲
Financial income75/76B€82€2▼
Recurring financial income75€82€2▼
Financial charges65/66B€5,756€4,646▼
Recurring financial charges65€5,756€4,646▼
Profit (loss) for the period before taxes9903€50,877€64,241▲
Income taxes67/77€13,922€16,590▲
Profit (loss) for the period9904€36,955€47,651▲
Profit (loss) for the period to be appropriated9905€36,955€47,651▲
Appropriation of the result
Profit (loss) to be appropriated9906€36,955€47,651▲
Transfer from equity791/2-€15,000
Transfer to equity691/2€36,955€47,651▲
To other reserves6921€36,955€47,651▲
Profit to be distributed694/7-€15,000
Return on contributions (dividend)694-€15,000

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,392€369€369€369€369€369€369=
Other operating charges640/8--€120€122€132€141€144▲ 2.6%
Gross operating margin9900€6,711€31,635€33,234€50,436€49,374€57,060€69,398▲ 21.6%
Operating profit (loss)9901€5,320€31,266€32,745€49,945€48,873€56,550€68,885▲ 21.8%
Financial income75/76B--€133€643€3€82€2▼ 97.6%
Recurring financial income75€0-€133€643€3€82€2▼ 97.6%
Financial charges65/66B--€2,826€5,004€5,247€5,756€4,646▼ 19.3%
Recurring financial charges65€415€2,816€2,826€5,004€5,247€5,756€4,646▼ 19.3%
Profit (loss) for the period before taxes9903€4,904€28,450€30,052€45,585€43,629€50,877€64,241▲ 26.3%
Income taxes67/77€2,184€8,565€9,812€13,744€11,576€13,922€16,590▲ 19.2%
Profit (loss) for the period9904€2,720€19,885€20,240€31,841€32,054€36,955€47,651▲ 28.9%
Profit (loss) for the period to be appropriated9905€2,720€19,885€20,240€31,841€32,054€36,955€47,651▲ 28.9%
Line2019202020212022202320242025Change
Assets
Total assets20/58€15,493€244,805€265,702€458,890€457,640€456,352€437,825▼ 4.1%
Fixed assets21/28€3,323€217,954€217,585€432,215€431,846€431,477€431,108▼ 0.1%
Tangible fixed assets22/27€3,323€2,954€2,585€2,215€1,846€1,477€1,108▼ 25.0%
Furniture and vehicles24--€2,585€2,215€1,846€1,477€1,108▼ 25.0%
Financial fixed assets28-€215,000€215,000€430,000€430,000€430,000€430,000=
Current assets29/58€12,170€26,851€48,117€26,675€25,794€24,875€6,717▼ 73.0%
Amounts receivable within one year40/41€7,287€15,175€26,153€21,856€11,322€19,264--
Trade receivables40--€6,397€21,856€10,783€19,264--
Other amounts receivable41--€19,756-€538---
Cash at bank and in hand54/58€4,042€11,209€20,848€3,901€14,216€5,527€6,440▲ 16.5%
Deferred charges and accrued income490/1--€1,116€918€257€85€277▲ 227%
Equity and liabilities
Total equity and liabilities10/49€15,493€244,805€265,702€458,890€457,640€456,352€437,825▼ 4.1%
Equity10/15€8,108€27,193€59,833€50,441€67,494€104,449€137,100▲ 31.3%
Contributions10/11€6,200-€18,600€18,600€18,600€18,600€18,600=
Reserves13€1,908€20,993€41,233€31,841€48,894€85,849€118,500▲ 38.0%
Distributable reserves133--€41,233€31,841€48,894€85,849€118,500▲ 38.0%
Amounts payable17/49€7,385€217,611€205,869€408,449€390,145€351,903€300,724▼ 14.5%
Amounts payable after more than one year17-€180,107€163,482€327,634€289,809€251,488€212,664▼ 15.4%
Financial debts170/4--€163,482€327,634€289,809€251,488€212,664▼ 15.4%
Amounts payable within one year42/48€6,900€37,224€42,155€80,253€99,813€93,336€87,271▼ 6.5%
Current portion of amounts payable after more than one year42--€18,000€40,424€40,955€41,492€42,037▲ 1.3%
Financial debts43---€5,853€2,706€3,884€4,890▲ 25.9%
Other loans439---€5,853€2,706€3,884€4,890▲ 25.9%
Trade debts44€2,217€1,618€189€996€373€321€8,850▲ 28×
Suppliers440/4--€189€996€373€321€8,850▲ 28×
Advances received on contracts in progress46-----€22,385--
Taxes, remuneration and social security45--€23,897€23,255€18,799€7,686€11,626▲ 51.3%
Taxes450/3--€23,897€19,727€13,255€7,686€11,626▲ 51.3%
Remuneration and social security454/9---€3,528€5,544---
Other amounts payable47/48--€69€9,726€36,981€17,568€19,868▲ 13.1%
Accrued charges and deferred income492/3--€232€562€523€7,078€790▼ 88.8%
Line2019202020212022202320242025Change
Profit (loss) for the period9904€2,720€19,885€20,240€31,841€32,054€36,955€47,651▲ 28.9%
+ Depreciation and write-downs630€1,392€369€369€369€369€369€369=
Operating cash flow (approximation)€4,112€20,254€20,609€32,210€32,423€37,324€48,020▲ 28.7%
Investment in fixed assets (approximation)--€215,000€0-€215,000€0€0€0-
Change in cash-€7,167€9,639-€16,947€10,315-€8,689€913-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference
31-12-2025 micro format 08-04-2026 2026-00076156
31-12-2024 micro format 18-07-2025 2025-00295780
31-12-2023 micro format 19-07-2024 2024-00270143
31-12-2022 micro format 02-07-2023 2023-00199051
31-12-2021 micro format 05-07-2022 2022-20150759
31-12-2020 micro format 15-06-2021 2021-20300459
31-12-2019 micro format 31-08-2020 2020-48900346

Similar companies · same sector, comparable size

Of the 5,204 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,893. 3,570 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.